Beta-Blockers Fail to Deliver Secondary Prevention Benefit in Key MI Patients

(MedPage Today) -- ATLANTA -- Beta-blockers had no additive benefit over contemporary therapies for people with acute myocardial infarction (MI) maintaining a preserved left ventricular ejection fraction (LVEF), the REDUCE-AMI randomized trial...
Source: MedPage Today Cardiovascular - Category: Cardiology Source Type: news